
CEPI commits up to US$80m to University of Oxford to develop vaccines
The US$80m strategic partnership of CEPI, which was established in 2016 in the wake of the Ebola virus outbreak in west Africa, the University of...

Radiotherapy R&D partnership
French-US company Orano Med is developing Lead-212 (212Pb) Targeted Alpha Therapy, which combines the ability of biological molecules such as...

UK invests in biopharma manufacturers
The agency announced that seventeen new projects will receive funding for cutting edge medicine manufacturing, delivered by the Innovate UK...

Spexis AG bags money for pivotal Phase III trial
The cash injection of US$2.5m that was led by SPRIM Global Investments (SGI) is urgently needed to finance US commercialisation of the company’s...

Biomethane fuel offers negative carbon footprint
German scientists at the University of Hohenheim have reported that fuels made from agricultural residues can even have a negative CO2 impact on bus...

Astraveus SAS bags €16.5m in seed financing
The oversubscribed seed round of Astraveus SAS was led by AdBio partners, co-syndicated with M Ventures, Johnson & Johnson Innovation –...

Resistance blocker of immune checkpoint inhibitors gets patented
DT-9081, Domain Therapeutics’ selective EP4 receptor antagonist, preclinically synergised with PD1-checkpoint blockers and shrinked tumours by...